New Migraine Medication 2025. Food and drug administration today approved ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or. Jamie grill / getty images.
Published on april 03, 2024. Abbvie announced that the u.s.